160 related articles for article (PubMed ID: 20416451)
1. Effects of montelukast on quality of life in patients with persistent allergic rhinitis.
Cingi C; Ozlugedik S
Otolaryngol Head Neck Surg; 2010 May; 142(5):654-8. PubMed ID: 20416451
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
4. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
Mucha SM; deTineo M; Naclerio RM; Baroody FM
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
[TBL] [Abstract][Full Text] [Related]
5. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.
Esteitie R; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):155-61. PubMed ID: 20674827
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
7. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
8. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S; Malice MP; Dass SB; Reiss TF
J Asthma; 2009 Nov; 46(9):878-83. PubMed ID: 19905912
[TBL] [Abstract][Full Text] [Related]
9. Montelukast effectively treats the nighttime impact of seasonal allergic rhinitis.
Meltzer EO; Philip G; Weinstein SF; LaForce CF; Malice MP; Dass SB; Santanello NC; Reiss TF
Am J Rhinol; 2005; 19(6):591-8. PubMed ID: 16402647
[TBL] [Abstract][Full Text] [Related]
10. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis.
Potter PC; Van Niekerk CH; Schoeman HS
Ann Allergy Asthma Immunol; 2003 Oct; 91(4):368-74. PubMed ID: 14582816
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
12. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
Virchow JC; Bachert C
Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
[TBL] [Abstract][Full Text] [Related]
14. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis.
Cingi C; Oghan F; Eskiizmir G; Yaz A; Ural A; Erdogmus N
Int Forum Allergy Rhinol; 2013 Oct; 3(10):801-6. PubMed ID: 23733270
[TBL] [Abstract][Full Text] [Related]
15. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
16. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study.
Goh BS; Ismail MI; Husain S
J Laryngol Otol; 2014 Mar; 128(3):242-8. PubMed ID: 24618303
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of montelukast for treating perennial allergic rhinitis.
Philip G; Williams-Herman D; Patel P; Weinstein SF; Alon A; Gilles L; Tozzi CA; Dass SB; Reiss TF
Allergy Asthma Proc; 2007; 28(3):296-304. PubMed ID: 17619558
[TBL] [Abstract][Full Text] [Related]
19. Long term treatment with montelukast and levocetirizine combination in persistent allergic rhinitis: review of recent evidence.
Adsule SM; Misra D
J Indian Med Assoc; 2010 Jun; 108(6):381-2. PubMed ID: 21121394
[TBL] [Abstract][Full Text] [Related]
20. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.
Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G;
J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
